Generation of a human immunodeficiency virus type 1 chronically infected monkey B cell line expressing low levels of endogenous TRIM5α

Journal of Cellular Physiology

Volumn 221, Issue 3, 2009, Pages 760-765

  Ridolfi, Barbara ^a   Catone, Stefania ^a   Sgarbanti, Marco ^a   Sernicola, Leonardo ^a   Battistini, Angela ^a   Parolin, Cristina ^b   Titti, Fausto ^a   Borsetti, Alessandra ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TRIPARTITE MOTIF PROTEIN 5; CARRIER PROTEIN; GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; TRIM5 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL BUDDING; CELL MEMBRANE; CELL TYPE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MONKEY; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; VIRION; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS STRAIN; AMINO ACID SUBSTITUTION; ANIMAL; CELL LINE; GENETICS; GROWTH, DEVELOPMENT AND AGING; MACACA; METABOLISM; MONONUCLEAR CELL; PHYSIOLOGY; SPECIES DIFFERENCE; TUMOR CELL LINE; ULTRASTRUCTURE; VIROLOGY;

CERCOPITHECIDAE; HUMAN IMMUNODEFICIENCY VIRUS 1; MAMMALIA;

AMINO ACID SUBSTITUTION; ANIMALS; B-LYMPHOCYTES; CARRIER PROTEINS; CELL LINE; CELL LINE, TUMOR; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GENE EXPRESSION; HIV CORE PROTEIN P24; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; LEUKOCYTES, MONONUCLEAR; MACACA FASCICULARIS; SPECIES SPECIFICITY; T-LYMPHOCYTES; VIRION; VIRUS REPLICATION;

EID: 70449732286     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21914     Document Type: Article

References (33)

1. Anderson JL, Campbell EM, Wu X, Vandegraaff N, Engelman A, Hope TJ. 2006. Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins. J Virol 80:9754-9760. (Pubitemid 44435649)
2. Arhel NJ, Nisole S, Carthagena L, Coutant F, Souque P, Brussel A, Estaquier J, Charneau P. 2008. Lack of endogenous TRIM5alpha-mediated restriction in rhesus macaque dendritic cells. Blood 112:3772-3776.
3. Berube J, Bouchard A, Berthoux L. 2007. Both TRIM5alpha and TRIMCyp have only weak antiviral activity in canine D17 cells. Retrovirology 4:68. (Pubitemid 350066538)
4. Besnier C, Takeuchi Y, Towers G. 2002. Restriction of lentivirus in monkeys. Proc Natl Acad Sci USA 99:11920-11925.
5. Coffin MJ, Hughes SH, Varmus HE. 1997. Retroviruses. NY, USA: CSHL Press. Cold Spring Harbor Laboratory Press. p. 335.
6. Cowan S, Hatziioannou T, Cunningham T, Muesing MA, Gottlinger HG, Bieniasz PD. 2002. Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism. Proc Natl Acad Sci USA 99:11914-11919. (Pubitemid 34994498)
7. Emerman M. 2006. How TRIM5alpha defends against retroviral invasions. Proc Natl Acad Sci U S A 103:5249-5250.
8. Goff SP. 2004. Retrovirus restriction factors. Mol Cell 16:849-859.
9. Hatziioannou T, Princiotta M, Piatak M, Jr., Yuan F, Zhang F, Lifson JD, Bieniasz PD. 2006. Generation of simian-tropic HIV-1 by restriction factor evasion. Science 314:95. (Pubitemid 44547747)
10. Hill MK, Shehu-Xhilaga M, Crowe SM, Mak J. 2002. Proline residues within spacer peptide p1 are important for human immunodeficiency virus type 1 infectivity, protein processing, and genomic RNA dimer stability. J Virol 76:11245-11253. (Pubitemid 35231279)
11. Igarashi T, Iyengar R, Byrum RA, Buckler-White A, Dewar RL, Buckler CE, Lane HC, Kamada K, Adachi A, Martin MA. 2007. Human immunodeficiency virus type 1 derivative with 7% simian immunodeficiency virus genetic content is able to establish infections in pig-tailed macaques. J Virol 81:11549-11552.
12. Kamada K, Igarashi T, Martin MA, Khamsri B, Hatcho K, Yamashita T, Fujita M, Uchiyama T, Adachi A. 2006. Generation of HIV-1 derivatives that productively infect macaque monkey lymphoid cells. Proc Natl Acad Sci USA 103:16959-16964. (Pubitemid 44737360)
13. Konvalinka J, Litterst MA, Welker R, Kottler H, Rippmann F, Heuser AM, Krausslich HG. 1995. An active-site mutation in the human immunodeficiency virus type 1 proteinase (PR) causes reduced PR activity and loss of PR-mediated cytotoxicity without apparent effect on virus maturation and infectivity. J Virol 69:7180-7186.
14. Liu P, Burdzy A, Sowers LC. 2004. DNA ligases ensure fidelity by interrogatingminor groove contacts. Nucleic Acids Res 32:4503-4511. (Pubitemid 39317728)
15. Luban J. 2007. Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infection. J Virol 81:1054-1061. (Pubitemid 46170755)
16. Moir S, Fauci AS. 2009. B cells in HIV infection and disease. Nat Rev Immunol 9: 235-245.
17. Moir S, Lapointe R, Malaspina A, Ostrowski M, Cole CE, Chun TW, Adelsberger J, Baseler M, Hwu P, Fauci AS. 1999. CD40-Mediated induction of CD4 and CXCR4 on B lymphocytes correlateswith restricted susceptibility to human immunodeficiency virus type 1 infection: Potential role of B lymphocytes as a viral reservoir. J Virol 73:7972-7980.
18. Munk C, Brandt SM, Lucero G, Landau NR. 2002. A dominant block to HIV-1 replication at reverse transcription in simian cells. Proc Natl Acad Sci USA 99:13843-13848. (Pubitemid 35215468)
19. Nakayama EE, Miyoshi H, Nagai Y, Shioda T. 2005. A specific region of 37 amino acid residues in the SPRY (B30.2) domain of African green monkey TRIM5alpha determines species-specific restriction of simian immunodeficiency virus SIVmac infection. J Virol 79:8870-8877. (Pubitemid 40934797)
20. Ohkura S, Yap MW, Sheldon T, Stoye JP. 2006. All three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restriction. J Virol 80:8554-8565. (Pubitemid 44384867)
21. Passerini LD, Keckesova Z, Towers GJ. 2006. Retroviral restriction factors Fv1 and TRIM5alpha act independently and can compete for incoming virus before reverse transcription. J Virol 80:2100-2105. (Pubitemid 43271517)
22. Rappocciolo G, Piazza P, Fuller CL, Reinhart TA, Watkins SC, Rowe DT, Jais M, Gupta P, Rinaldo CR. 2006. DC-SIGN on B lymphocytes is required for transmission of HIV-1 to T lymphocytes. PLoS Pathog 2:e70.
23. Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, Luzi L, Riganelli D, Zanaria E, Messali S, Cainarca S, Guffanti A, Minucci S, Pelicci PG, Ballabio A. 2001. The tripartite motif family identifies cell compartments. EMBO J 20:2140-2151. (Pubitemid 32410584)
24. Ridolfi B, Titti F, Fulgenzi D, Maggiorella MT, Tinari A, Superti F, Parolin C, Ensoli B, Borsetti A. 2004. Infection of a simian B cell line by human and simian immunodeficiency viruses. AIDS Res Hum Retroviruses 20:723-732. (Pubitemid 39037503)
25. Rold CJ, Aiken C. 2008. Proteasomal degradation of TRIM5alpha during retrovirus restriction. PLoS Pathog 4:e1000074. (Pubitemid 351811521)
26. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J. 2004. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427:848-853. (Pubitemid 38297747)
27. Stremlau M, Perron M, Welikala S, Sodroski J. 2005. Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction. J Virol 79:3139-3145. (Pubitemid 40270592)
28. Stremlau M, Perron M, Lee M, Li Y, Song B, Javanbakht H, az-Griffero F, Anderson DJ, Sundquist WI, Sodroski J. 2006. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc Natl Acad Sci USA 103:5514-5519.
29. Titti F, Zamarchi R, Maggiorella MT, Sernicola L, Geraci A, Negri DR, Borsetti A, Menin C, D'Andrea E, Modesti A, Masuelli L, Verani P, Chieco-Bianchi L, Amadori A. 2002. Infection of simian B lymphoblastoid cells with simian immunodeficiency virus is associated with upregulation of CD23 and CD40 cell surface markers. J Med Virol 68:129-140.
30. Wu X, Anderson JL, Campbell EM, Joseph AM, Hope TJ. 2006. Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infection. Proc Natl Acad Sci USA 103:7465-7470.
31. Yap MW, Nisole S, Lynch C, Stoye JP. 2004. Trim5alpha protein restricts both HIV-1 and murine leukemia virus. Proc Natl Acad Sci USA 101:10786-10791.
32. Ylinen LM, Keckesova Z, Wilson SJ, Ranasinghe S, Towers GJ. 2005. Differential restriction of human immunodeficiency virus type 2 and simian immunodeficiency virus SIVmac by TRIM5alpha alleles. J Virol 79:11580-11587.
33. Zheng YH, Peterlin BM. 2005. Intracellular immunity to HIV-1: Newly defined retroviral battles inside infected cells. Retrovirology 2:25.